News

Feds Loosen Grip on Cannabis

PR Newswire · Royal Emerald Pharmaceuticals · last updated
RapidGrow Royal EmeraldThe Drug Enforcement Administration (DEA) issued three licenses for bulk manufacturing, analytical lab and import in December. “We are excited and very happy to receive these DEA licenses for cannabis research,” said Mark Crozier, Founder and CEO of Royal Emerald Pharmaceuticals. About Royal Emerald PharmaceuticalsRoyal Emerald Pharmaceuticals is committed to replace current medications by developing alternative pharmaceuticals that will be safe and effective without producing harmful side effects or addiction. We guarantee superior quality pharmaceuticals by complying with the current Good Manufacturing Practices (cGMP) established by the Food and Drug Administration (FDA). Media ContactsJackie Devereaux, Royal Emerald Pharmaceuticals19-855-7905[email protected]Tyler Bryant, Interdependence Public Relations813-951-4169[email protected]SOURCE Royal Emerald Pharmaceuticals
View full article

here today, more tomorrow

We’ve launched briefing.center with a focus on the press and media.

And we’ve added Citizen Cartwright, a daily quick-read news summary by veteran Washington journalist Linda Cartwright. We’ve also created a new voting rights knowledge center for Citizen Cartwright subscribers. (You can sign up for a dedicated morning email at citizencartwright.com.)

You can sign up here for full access to press and media and Citizen Cartwright on briefing.center.

You can use briefing.center as the center of your information management, or just one of your tools. We’re happy to discuss your information needs.

Sign up